Angiogenesis in adenocarcinoma of the uterine cervix
β Scribed by Tsunehisa Kaku; Toshio Hirakawa; Toshiharu Kamura; Satoshi Amada; Naoko Kinukawa; Hiroaki Kobayashi; Kunihiro Sakai; Kazuya Ariyoshi; Kenzo Sonoda; Hitoo Nakano
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 259 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
BACKGROUND.
Angiogenesis is essential for tumor growth, progression, and metastases. Microvessel density (MVD), a measure of tumor angiogenesis, has been found to have prognostic significance in many tumor types for predicting metastasis and survival. Between 1979 -1989, 56 cases of FIGO Clinical Stage I and II adenocarcinoma of the uterine cervix treated by hysterectomy were reviewed histologically.
METHODS.
All hysterectomy specimens were stained immunohistologically for factor VIIIrelated antigen. MVD was counted in a Ο«200 field ( 0.785 mm 2 per field) in the most active area of neovascularization. Results were expressed as the highest number of microvessels identified within any single Ο«200 field. MVD and several other prognostic parameters were examined for correlation with progression free survival (PFS) and overall survival (OS) by a multivariate analysis according to the Cox proportional hazards model.
RESULTS.
In early adenocarcinoma of the uterine cervix, MVD was increased significantly in invasive areas compared with adjacent nonneoplastic areas (median: 62.5 [range, 30 -105] vs. median: 36.5 [range, 23-47]; P Ο 0.0003). MVD also was significantly correlated with ascites cytology (P Ο 0.0377). There was no correlation between microvessel count and lymph node status, depth of invasion, disease stage, lymph-vascular space invasion, grade, or parametrial involvement .
Patients with high MVD (Υ 75) had significantly worse PFS and OS than those with low MVD (Ο½ 75) (log rank test, P Ο 0.0180 and 0.0199, respectively). Multivariate analysis showed that MVD correlated significantly and independently with PFS and OS.
π SIMILAR VOLUMES
Cervical cancer remains a significant health problem. New strategies based on the molecular aspects of cervical carcinogenesis are needed. Chemoprevention represents a novel strategy for cervical cancer prevention. Our group plans phase I and II trials using β£-difluoromethylornithine, a suicide inhi